agilon health Announces Secondary Offering
September 07 2021 - 4:07PM
Business Wire
agilon health, inc. (NYSE: AGL), the company transforming health
care for seniors by empowering primary-care physicians to focus on
the entire health of their patients, announced the launch of an
underwritten secondary public offering of 17,000,000 shares of its
common stock by certain selling stockholders. Certain of these
selling stockholders expect to grant the underwriters a 30-day
option to purchase up to an additional 2,550,000 shares of agilon’s
common stock. agilon health will not receive any proceeds from the
secondary offering.
J.P. Morgan, Goldman Sachs & Co. LLC, and BofA Securities
are acting as lead book-running managers for the proposed offering.
Deutsche Bank Securities, Wells Fargo Securities, Wolfe | Nomura
Strategic Alliance, William Blair, and Truist Securities are acting
as additional book-running managers.
The joint book-running managers of agilon health’s recently
completed initial public offering are waiving a lockup restriction
in respect to 714,011 shares of the company’s common stock held by
certain officers and directors of the company, which may be sold in
the announced secondary public offering.
The proposed secondary offering is being made only by means of a
prospectus. Copies of the preliminary prospectus, when available,
may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge
Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717,
or by telephone at (866) 803-9204, or by email at
prospectus-eq_fi@jpmchase.com; or Goldman Sachs & Co. LLC,
Attention: Prospectus Department, 200 West Street, New York, New
York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or
by emailing prospectus-ny@ny.email.gs.com; or BofA Securities,
Attention: Prospectus Department, NC1-004-03-43, 200 North College
Street, 3rd Floor, Charlotte, NC 28255-0001, or by email at
dg.prospectus_requests@bofa.com.
A registration statement relating to these securities has been
filed with the SEC but has not yet become effective. These
securities may not be sold nor may offers to buy be accepted prior
to the time the registration statement becomes effective. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy securities, nor shall there be any
sale of these securities in any state or jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or
jurisdiction. Any offers, solicitations or offers to buy, or any
sales of securities will be made in accordance with the
registration requirements of the Securities Act of 1933, as
amended.
“Wolfe | Nomura Strategic Alliance” is the marketing name used
by Wolfe Research Securities and Nomura Securities International,
Inc. in connection with certain equity capital markets activities
conducted jointly by the firms. For these activities, Nomura serves
as the underwriter, placement agent, or initial purchaser (as
applicable) and Wolfe Research Securities provides sales support
services, investor education, and/or independent equity research
services.
About agilon health
agilon health is transforming health care for seniors by
empowering primary-care physicians to focus on the entire health of
their patients. Through our partnerships and our platform, agilon
is leading the nation in creating the system we need – one built on
the value of care, not the volume of fees. We honor the
independence of local physicians and serve as their partners so
they can be the doctors they trained to be. agilon provides the
capital, data, payor relationships, executive experience and
contract support that allow physician groups to take on the risk of
total care for their most vulnerable patients. The result:
healthier communities, and doctors who can devote the right amount
of time with the patients who need it most. With rapidly growing
appeal, agilon is scaled to grow and is here to help our nation’s
best independent physician groups have a sustained, thriving
future. Together, we are reinventing primary care.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute
“forward-looking statements,” including with respect to the
proposed secondary offering. No assurance can be given that the
offering discussed above will be completed on the terms described,
or at all. Forward-looking statements are subject to numerous
conditions, many of which are beyond the control of agilon health,
including those set forth in the Risk Factors section of agilon
health’s most recent Quarterly Report on Form 10-Q and in the
registration statement for this offering and the preliminary
prospectus included therein, as filed with the Securities and
Exchange Commission. Copies are available on the SEC’s website at
www.sec.gov. agilon health undertakes no obligation to update these
statements for revisions or changes after the date of this press
release, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210907005857/en/
Investor Contact Matthew Gillmor VP, Investor Relations
investor.relations@agilonhealth.com Media Contact Claire
Mulhearn VP, Corporate Communications media@agilonhealth.com
Agilon Health (NYSE:AGL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Agilon Health (NYSE:AGL)
Historical Stock Chart
From Oct 2023 to Oct 2024